Media Summary: This is the fifth in a series of videos designed to let patients, caregivers, and patient advocates know that FDA wants to hear from ... This video featuring Lee Ann Browning-McNee of the Reagan-Udall Foundation is part of NORD's educational series, "Rare ... The first of our series of educational videos on pre-approval

Expanded Access Programs And Barth Syndrome Drug Candidate - Detailed Analysis & Overview

This is the fifth in a series of videos designed to let patients, caregivers, and patient advocates know that FDA wants to hear from ... This video featuring Lee Ann Browning-McNee of the Reagan-Udall Foundation is part of NORD's educational series, "Rare ... The first of our series of educational videos on pre-approval J. Paul Phillips provides an overview of the FDA's An overview on the submission process for emergency and non-emergency Big news in pharmacology! On September 19th, 2025, the FDA granted accelerated approval to elamipretide (Forzinity) — the ...

This Research Rounds was presented by Holly Fernandez Lynch, JD, MBe, Assistant Professor of Medical Ethics and Law at ... We asked Marinus to tell us about their new The new frontier: Future clinical trials and you Kate McCurdy — Emerita, Scientific & Medical Advisory Board.

Photo Gallery

Expanded Access Programs and Barth Syndrome Drug Candidate
Expanded Access
Expanded Access Part 1: Introduction
What is Expanded Access?
FDA's Expanded Access for Treatment Use
Patients Matter: What is Expanded Access?
Navigating FDA Expanded Access and Compassionate Use - Rare Disease Drug Development Series Preview
Expanded Access To New Medicines:  How it Works in the U.S.
Overview of FDA's Expanded Access Program (13/14) REdI 2017
Expanded Access Part 2: How to Submit a Single Patient IND
Barth Syndrome Breakthrough: How Elamipretide Works | Pharmacology Explained
Early Access Programs - All You Need To Know | myTomorrows
View Detailed Profile
Expanded Access Programs and Barth Syndrome Drug Candidate

Expanded Access Programs and Barth Syndrome Drug Candidate

Donna Cowan, Associate Director

Expanded Access

Expanded Access

Expanded access

Expanded Access Part 1: Introduction

Expanded Access Part 1: Introduction

What is

What is Expanded Access?

What is Expanded Access?

This week's briefing focuses on

FDA's Expanded Access for Treatment Use

FDA's Expanded Access for Treatment Use

This video covers the FDA's

Patients Matter: What is Expanded Access?

Patients Matter: What is Expanded Access?

This is the fifth in a series of videos designed to let patients, caregivers, and patient advocates know that FDA wants to hear from ...

Navigating FDA Expanded Access and Compassionate Use - Rare Disease Drug Development Series Preview

Navigating FDA Expanded Access and Compassionate Use - Rare Disease Drug Development Series Preview

This video featuring Lee Ann Browning-McNee of the Reagan-Udall Foundation is part of NORD's educational series, "Rare ...

Expanded Access To New Medicines:  How it Works in the U.S.

Expanded Access To New Medicines: How it Works in the U.S.

The first of our series of educational videos on pre-approval

Overview of FDA's Expanded Access Program (13/14) REdI 2017

Overview of FDA's Expanded Access Program (13/14) REdI 2017

J. Paul Phillips provides an overview of the FDA's

Expanded Access Part 2: How to Submit a Single Patient IND

Expanded Access Part 2: How to Submit a Single Patient IND

An overview on the submission process for emergency and non-emergency

Barth Syndrome Breakthrough: How Elamipretide Works | Pharmacology Explained

Barth Syndrome Breakthrough: How Elamipretide Works | Pharmacology Explained

Big news in pharmacology! On September 19th, 2025, the FDA granted accelerated approval to elamipretide (Forzinity) — the ...

Early Access Programs - All You Need To Know | myTomorrows

Early Access Programs - All You Need To Know | myTomorrows

What is an

Americans With Rare Barth Syndrome Losing Hope in FDA

Americans With Rare Barth Syndrome Losing Hope in FDA

Barth Syndrome

Expanded Access Programs (Compassionate Use)

Expanded Access Programs (Compassionate Use)

Expanded Access Programs

Academic Oncologists and the Expanded Access Pathway to Investigational Drugs

Academic Oncologists and the Expanded Access Pathway to Investigational Drugs

This Research Rounds was presented by Holly Fernandez Lynch, JD, MBe, Assistant Professor of Medical Ethics and Law at ...

Expanded Access Webinar

Expanded Access Webinar

Expanded Access

Marinus Expanded Access Program

Marinus Expanded Access Program

We asked Marinus to tell us about their new

A Historic Moment: Our Community at the FDA Advisory Committee for Elamipretide

A Historic Moment: Our Community at the FDA Advisory Committee for Elamipretide

In October 2024, the

New Frontier (Family Sessions)

New Frontier (Family Sessions)

The new frontier: Future clinical trials and you Kate McCurdy — Emerita, Scientific & Medical Advisory Board.

An Introduction to Preapproval Access: Expanded Access, Compassionate Use & Right to Try

An Introduction to Preapproval Access: Expanded Access, Compassionate Use & Right to Try

A broad overview of what it means to